SANTA ANA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and ...

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that one of its scientific co ...

President Trump on Monday called on drugmakers to lower their prices within the next month to be closer to those charged in ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Novo Holdings led a $92 million Series A investment in Kivu Biosciences, a San Francisco biotech focusing on the ... Trump said he will sign an order today to cut prescription drug prices in ...

The company is the fourth spin-out from the world-renowned university to be led ... Huntingdon and his partnership with Medicxi is XO1, a biotech which was sold to Janssen in 2015 for an ...

Civil servants moved out of London 'might' have to take pay cut The government's big announcement today is that it ... Follow along for the very latest political news. It's goodnight from the ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...

Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big Tobacco ...